Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

The hair disorder was caused by abnormal protein formation, making hair easily damaged.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

The wavy coat in NCT mice is caused by multiple genes, including a mutation in the Prss53 gene.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Changes in NRF2 levels may contribute to hair loss in Egyptian men.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

A new genetic mutation linked to Hutchinson-Gilford progeria syndrome was found in China.

New mutations in hair keratin genes can change hair structure and cause monilethrix, with nail issues more common in certain gene mutations.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

A new mutation in the STS gene causes X-linked ichthyosis, even in rare female cases.

Alitretinoin can effectively treat frontal fibrosing alopecia.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

TGFβ-2 may cause hair loss in androgenetic alopecia.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

RNA-based treatments show promise for managing Hutchinson-Gilford Progeria Syndrome.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.